Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
After a person is diagnosed with gallbladder cancer, doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.
The earliest stage gallbladder cancers (called carcinoma in situ) are stage 0. Stages then range from stages I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter means a lower stage.
Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
Nearly all gallbladder cancers start in the epithelium (the inside wall of the gallbladder). Over time they grow through the various layers toward the outside of the gallbladder. They may also grow to fill up some or all the space inside the gallbladder at the same time.
The staging system most often used for gallbladder cancer is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information:
The depth that a tumor grows from the inside (epithelium layer) through the other outer layers (all the way through the serosa) is a key part of staging.
The system described below is the most recent AJCC system, effective January 2018. This system is used to stage cancers of the gallbladder as well as cancers that start in the cystic duct (the tube that carries bile away from the gallbladder).
The gallbladder staging system uses the pathologic stage (also called the surgical stage) which is determined by examining the tissue removed during an operation. Sometimes, if surgery can't be done right away or at all, the cancer will be given a clinical stage instead. This is based on the results of a physical exam, biopsy, and imaging tests. The clinical stage will be used to help plan treatment. Sometimes, though, the cancer has spread further than the clinical stage estimates, and may not predict the patient’s outlook as accurately as a pathologic stage.
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced.
Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage. For more on this see Cancer Staging.
Cancer staging can be complex, so ask your doctor to explain it to you in a way you understand.
AJCC Stage |
Stage grouping |
Stage description* |
0 |
Tis N0 M0 |
Cancer is only in the epithelium (the inner layer of the gallbladder) and has not grown into deeper layers of the gallbladder (Tis). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
I |
T1 N0 M0 |
The tumor has grown into the lamina propria or the muscle layer (muscularis) (T1). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
IIA |
T2a N0 M0 |
The cancer has grown through the muscle layer into the fibrous tissue on the side of the peritoneum (the lining of the abdominal cavity) (T2a). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
IIB |
T2b N0 M0 |
The cancer has grown through the muscle layer into the fibrous tissue on the side of the liver, but has not invaded the liver (T2b). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
IIIA |
T3 N0 M0 |
The cancer has grown through the serosa (the outermost covering of the gallbladder) and/or it has grown directly into the liver and/or one nearby structure like the stomach, duodenum (first part of the small intestine), colon, pancreas, or bile ducts outside the liver (T3). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
IIIB |
T1-3 N1 M0 |
The cancer may or may not have grown outside of the gallbladder into the liver and/or one other nearby structure, but it has not grown into the main blood vessels leading into the liver (portal vein or hepatic artery) (T1 to T3). It has spread to no more than 3 nearby lymph nodes (N1). It has not spread to distant sites (M0). |
IVA |
T4 N0 or N1 M0 |
The tumor has grown into one of the main blood vessels leading into the liver (portal vein or hepatic artery) or it has grown into 2 or more structures outside of the liver (T4). It may or may not have spread to no more than 3 nearby lymph nodes (N0 or N1). It has not spread to distant sites (M0). |
IVB |
Any T N2 M0 |
The primary tumor may or may not have grown outside the gallbladder. The cancer has spread to 4 or more nearby lymph nodes (N2). It has not spread to distant sites (M0). |
OR |
||
Any T Any N M1 |
The primary tumor may or may not have grown outside the gallbladder. The cancer may or may not have spread to nearby lymph nodes. It has spread to distant sites such as the liver, peritoneum (the lining of the abdomen [belly]), or the lungs (M1). |
* The following additional categories are not listed on the table above:
Besides your stage, there are other factors that can affect your prognosis (outlook).
The grade describes how closely the cancer cells look like normal gallbladder cells when seen with a microscope.
The scale used for grading gallbladder cancer is from 1 to 3.
Low-grade cancers (G1) tend to grow and spread more slowly than high-grade (G3) cancers. Most of the time, the outlook is better for Grade 1 and Grade 2 cancers than it is for Grade 3 cancers of the same stage for gallbladder cancer.
The specific type of gallbladder cancer you have can influence your outlook. Rare cancer types such as squamous and adenosquamous carcinomas of the gallbladder tend to have a worse prognosis (outlook) than adenocarcinomas (the most common type) and papillary carcinomas.
If cancer cells are seen in small blood vessels (vascular) or lymph vessels (lymphatics) under the microscope, it's called lymphovascular invasion. When cancer is growing in these vessels, there's a greater chance that it has spread outside the gallbladder. Gallbladder cancers with lymphovascular invasion tend to have a poor prognosis.
If the entire gallbladder tumor can be removed with surgery, it can impact the overall outlook. Cancers that can be removed completely by surgery tend to have a better outlook than those that cannot.
Only a small percentage of gallbladder cancers are resectable when they're first found.
American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 201-205;303-309.
Samuel S, Mukherjee S, Ammannagari N, et al. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One. 2018;13(6).
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Last Revised: July 12, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.